{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:59:24Z","timestamp":1792645164435,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220818103207016"],"award-info":[{"award-number":["JCYJ20220818103207016"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2412300"],"award-info":[{"award-number":["2023YFC2412300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010024"],"award-info":[{"award-number":["2022A1515010024"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.colsurfb.2024.114457","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:35:29Z","timestamp":1734161729000},"page":"114457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Hyaluronic acid modified liposomes with enhanced transdermal delivery of methotrexate for psoriasis treatment"],"prefix":"10.1016","volume":"247","author":[{"given":"Penglei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-0131","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2024.114457_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2024.114457_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5114\/ada.2020.94832","article-title":"Pathogenesis of psoriasis in the \u201comic\u201d era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances","volume":"37","author":"Samotij","year":"2020","journal-title":"Post. Dermatol. Alergol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119968","article-title":"Hyaluronic acid-based supramolecular medicine with polyamines sequestration capability for cooperative anti-psoriasis","volume":"296","author":"Ding","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2024.114457_bib5","doi-asserted-by":"crossref","unstructured":"Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment, Acta Pharmaceutica Sinica B 12 (2022) 339\u2013352. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.019.","DOI":"10.1016\/j.apsb.2021.07.019"},{"key":"10.1016\/j.colsurfb.2024.114457_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574886315666200128095958","article-title":"Treatment of psoriasis: a comprehensive review of entire therapies","volume":"15","author":"Bakshi","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.colsurfb.2024.114457_bib7","first-page":"369","article-title":"Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up","volume":"10","author":"Malatjalian","year":"1996","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5114\/ada.2021.108445","article-title":"Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy","volume":"39","author":"Zhu","year":"2022","journal-title":"Post. Dermatol. Alergol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2340\/00015555-1286","article-title":"Dermal distribution of hyaluronan in psoriatic arthritis; coexistence of CD44, MMP3 and MMP9","volume":"92","author":"Lindqvist","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cod.13463","article-title":"CD44 expression in human skin: High expression in irritant and allergic contact dermatitis and moderate expression in psoriasis lesions in comparison with healthy controls","volume":"82","author":"Lugovi\u0107-Mihi\u0107","year":"2020","journal-title":"Contact Dermat."},{"key":"10.1016\/j.colsurfb.2024.114457_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1042\/BST20190803","article-title":"How does methotrexate work?","volume":"48","author":"Alqarni","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.colsurfb.2024.114457_bib12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12325-015-0276-3","article-title":"Utilization of subcutaneous methotrexate in rheumatoid arthritis patients after failure or intolerance to oral methotrexate: a multicenter cohort study","volume":"33","author":"Branco","year":"2016","journal-title":"Adv. Ther."},{"key":"10.1016\/j.colsurfb.2024.114457_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.23144","article-title":"Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial","volume":"58","author":"Braun","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.colsurfb.2024.114457_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4155\/tde.12.3","article-title":"Transdermal delivery of methotrexate: past, present and future prospects","volume":"3","author":"Prasad","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.colsurfb.2024.114457_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/1061186X.2018.1433680","article-title":"Drug delivery targets and systems for targeted treatment of rheumatoid arthritis","volume":"26","author":"Feng","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2024.114457_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/biomedicines8120630","article-title":"Increased encapsulation efficiency of methotrexate in liposomes for rheumatoid arthritis therapy","volume":"8","author":"Guimar\u00e3es","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.colsurfb.2024.114457_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejpb.2012.05.016","article-title":"Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier","volume":"82","author":"Yang","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2024.114457_bib19","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01725-w","article-title":"Potential of sonophoresis as a skin penetration technique in the treatment of rheumatoid arthritis with transdermal patch","author":"Vaidya","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2024.114457_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106711","article-title":"Methotrexate-loaded hyaluronan-modified liposomes integrated into dissolving microneedles for the treatment of psoriasis","volume":"195","author":"Shen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2024.114457_bib21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2217\/nnm-2018-0002","article-title":"Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy","volume":"13","author":"Jain","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2024.114457_bib22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijpharm.2012.10.019","article-title":"Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery","volume":"441","author":"Wang","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114457_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.supflu.2010.02.005","article-title":"Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology","volume":"54","author":"Naik","year":"2010","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.colsurfb.2024.114457_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2014.05.027","article-title":"Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting","volume":"471","author":"Tiantian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114457_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0003-2697(83)90258-0","article-title":"Characterization of a fluorescence assay to monitor changes in the aqueous volume of lipid vesicles","volume":"134","author":"Kendall","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.colsurfb.2024.114457_bib26","doi-asserted-by":"crossref","unstructured":"Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23\/IL-17 Axis1 | The Journal of Immunology | American Association of Immunologists, (n.d.). \u3008https:\/\/journals.aai.org\/jimmunol\/article\/182\/9\/5836\/104045\/Imiquimod-Induced-Psoriasis-Like-Skin-Inflammation\u3009 (accessed July 11, 2024).","DOI":"10.4049\/jimmunol.0802999"},{"key":"10.1016\/j.colsurfb.2024.114457_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.carbpol.2016.08.021","article-title":"Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery","volume":"155","author":"Lin","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2024.114457_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210296","article-title":"Hyaluronic acid: a powerful biomolecule with wide-ranging applications\u2014a comprehensive review","volume":"24","author":"Iaconisi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2024.114457_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.colsurfb.2017.03.008","article-title":"Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release","volume":"154","author":"Nguyen","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2024.114457_bib30","doi-asserted-by":"crossref","unstructured":"T. Wang, Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44, (2017). https:\/\/doi.org\/10.1186\/s12951-016-0245-2.","DOI":"10.1186\/s12951-016-0245-2"},{"key":"10.1016\/j.colsurfb.2024.114457_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103193","article-title":"Hyaluronic acid-coated shikonin liposomes for the treatment of triple-negative breast cancer via targeting tumor cells and amplification of oxidative stress","author":"Meng","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jconrel.2023.03.049","article-title":"Hyaluronic acid and HA-modified cationic liposomes for promoting skin penetration and retention","volume":"357","author":"Ni","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114457_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4155\/tde-2020-0122","article-title":"Liposomes and transferosomes: a breakthrough in topical and transdermal delivery","volume":"12","author":"Sapkota","year":"2021","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.colsurfb.2024.114457_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejps.2009.10.016","article-title":"New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker","volume":"39","author":"Bahia","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2024.114457_bib35","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/jid.2012.461","article-title":"Spatially resolved two-color diffusion measurements in human skin applied to transdermal liposome penetration","volume":"133","author":"Brewer","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib36","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1039\/D1TB00557J","article-title":"Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy","volume":"9","author":"Yu","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2024.114457_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1084\/jem.179.3.1059","article-title":"Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo","volume":"179","author":"Bogen","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.colsurfb.2024.114457_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","article-title":"Advanced characterization of imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2024.114457_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2\u2013IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114457_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.colsurfb.2024.114457_bib42","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J. Invest. Dermatol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524007161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524007161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:34:40Z","timestamp":1737318880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776524007161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"alternative-id":["S0927776524007161"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114457","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid modified liposomes with enhanced transdermal delivery of methotrexate for psoriasis treatment","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114457"}}